Dashboard
Manage Tickers

ACHV


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

achieve-life-sciences-publishes-new-data-in-thorax-entitled-cytisinicline-for-smoking-cessation-in-individuals-with-self-reported-copd-a-post-hoc-analysis-of-the-orca-2-and-orca-3-trials
Achieve Life Sciences Publishes New Data I...
09/22/2025 12:38:00

achieve-life-sciences-appoints-craig-donnelly-to-coo
Achieve Life Sciences Appoints Craig Donne...
09/18/2025 12:32:56

- Achieve Life Sciences, Inc. (NASDAQ:ACHV), a late-stage specialty pharmaceutical company focused on the global development an...

fda-accepts-achieve-life-sciences-cytisinicline-new-drug-application-for-treatment-for-smoking-cessation-in-adults
FDA Accepts Achieve Life Sciences' Cytisin...
09/03/2025 12:32:38

achieve-life-sciences-inches-closer-to-fda-nod-for-first-new-quit-smoking-drug-in-20-years
Achieve Life Sciences Inches Closer To FDA...
08/21/2025 18:11:26

HC Wainwright backs Achieve Life Sciences with a Buy rating as cytisinicline nears potential 2026 FDA approval, targeting a lar...

hc-wainwright--co-initiates-coverage-on-achieve-life-sciences-with-buy-rating-announces-price-target-of-12
HC Wainwright & Co. Initiates Coverage On ...
08/21/2025 11:10:08

HC Wainwright & Co. analyst Brandon Folkes initiates coverage on Achieve Life Sciences (NASDAQ:ACHV) with a Buy rating a...

achieve-life-sciences-q2-eps-037-beats-038-estimate
Achieve Life Sciences Q2 EPS $(0.37) Beats...
08/07/2025 11:30:31

Achieve Life Sciences (NASDAQ:ACHV) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of...

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
06/27/2025 17:05:50

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
06/27/2025 12:07:16

reported-earlier-achieve-life-sciences-prices-45m-public-offering-of-15m-shares-and-15m-accompanying-warrants-at-3-each
Reported Earlier, Achieve Life Sciences Pr...
06/27/2025 06:19:13

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
06/26/2025 21:05:50

achieve-life-sciences-announces-proposed-underwritten-public-offering-size-not-disclosed
Achieve Life Sciences Announces Proposed U...
06/26/2025 20:04:21

achieve-life-sciences-submits-nda-to-fda-for-cytisinicline-as-a-treatment-for-nicotine-dependence-for-smoking-cessation
Achieve Life Sciences Submits NDA To FDA F...
06/26/2025 20:03:03

achieve-life-sciences-to-present-phase-3-orca-3-study-data-at-2025-ats-international-conference
Achieve Life Sciences To Present Phase 3 O...
05/20/2025 12:35:11

achieve-life-sciences-q1-eps-037-inline
Achieve Life Sciences Q1 EPS $(0.37), Inline
05/13/2025 11:30:40

Achieve Life Sciences (NASDAQ:ACHV) reported quarterly losses of $(0.37) per share which met the analyst consensus estimate. Th...

Core News & Articles
Earnings Scheduled For May 13, 2025
05/13/2025 08:32:43

what-to-expect-from-achieve-life-sciencess-earnings
What to Expect from Achieve Life Sciences'...
05/12/2025 20:07:45

achieve-life-sciences-says-cytisinicline-phase-3-orca-3-trial-results-showed-increase-in-quitting-and-reduction-in-nicotine-cravings-for-cytisinicline-treated-participants-compared-to-placebo
Achieve Life Sciences Says Cytisinicline P...
04/21/2025 15:22:34

ORCA-3 Demonstrated a Significant Increase in Quitting and Reduction in Nicotine Cravings for Cytisinicline-Treated Participant...

achieve-life-sciences-q4-eps-036-misses-032-estimate
Achieve Life Sciences Q4 EPS $(0.36) Misse...
03/11/2025 11:36:00

Achieve Life Sciences (NASDAQ:ACHV) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate ...

earnings-scheduled-for-march-11-2025
Earnings Scheduled For March 11, 2025
03/11/2025 08:32:14

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION